American Academy of Neurology (AAN)
75^th Annual Meeting in Boston, Mass. (April 22-28, 2023)

• Cognitive function remains associated with global functional impairment in profound dementia due to Alzheimer's disease and dementia with Lewy bodies.
  

  Rampalli I, Pavlik V, Yu M, Bishop J, Lin C

International Neuropsychological Society (INS)
51^st Annual Meeting in San Diego, Calif. (Feb. 1-4, 2023)

• Psychometric properties of the Verbal Series Attention Test: Preliminary findings.
  

  McCauley SR, York MK, Strutt AM, Stinson JM, Henry SK, Windham VA, et al.

American Academy of Neurology (AAN)
74^th Annual Meeting in Seattle, Wash. (April 2-7, 2022)

• Gender discrepancies in neurologist compensation.
  

  Yu MM, Merillat SA, Weathers AL, Evans DA, Wolf RA, Ney JP

Texas Scottish Rite Hospital for Children
44^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 24-25, 2022)

• Impaired large fiber sensory exam with normal NCS.
  [Oral Presentation]
  

  Komal F, Sharp L, Abid F

2021 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 26-30, 2021)

• U.S. POINTER: Lessons learned about delivery of a multi-domain lifestyle intervention during the COVID-19 pandemic.
  

  Baker LD, Espeland MA, Whitmer RA, Kivipelto M, Antkowiak S, Chavin M, et al.

Baylor College of Medicine (BCM)
4^th Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (May 20, 2021)

• Effects of narcolepsy during pregnancy on adverse maternal-fetal outcomes.
  

  Wilson A, Dongarwar D, Carter K, Marroquin M, Salihu HM

American Neurological Association (ANA)
145^th Annual Meeting in Los Angeles, Calif. (Oct. 4-6, 2020)

• Neurosarcoidosis related vision loss mimicking idiopathic intracranial hypertension.
  

  Lie M, Acosta GT, Melendez-Zaidi A, Sharp L

2020 Alzheimer's Association International Conference (AAIC)
Virtual Meeting (July 27-31, 2020)

• US-POINTER (USA).
  [Platform Presentation]
  

  Baker LD, Espeland MA, Kivipelto M, Whitmer RA, Snyder HM, Carrillo MC, et al.

Baylor College of Medicine (BCM)
2^nd Annual Center of Excellence in Health Equity, Training and Research Summer Research Summit in Houston, Texas (June 18, 2019)

• Spanish/cross-cultural fellowship in neuropsychology: A response to the needs of the Houston Hispanic community.
  

  Baena E, Vuong KD, Stinson JM, McCauley SR, York MK, Strutt AM

• CCACTUS - Cross-cultural consortium on aging and cognition in Texas, U.S.: The development of a neuropsychology data repository.
  

  Strutt AM, Armendariz V, Vuong KD, Rossetti A

American Academy of Neurology (AAN)
71^st Annual Meeting in Philadelphia, Penn. (May 4-10, 2019)

• When Occam's razor fails: A McArdle disease diagnosis following idiopathic transverse myelitis.
  

  Chen W, Dunham SR, Sharp L

• A case of hepatocellular carcinoma presenting with myasthenia gravis.
  

  Fussner S, Garg T, Sharp L

• The potential role of estrogen in moderating symptom severity in women with RYR1-related myopathy.
  

  Sharp L, Pleitez MY, Yee R, Hamilton S

North American Neuro-Ophthalmology Society (NANOS)
45^th Annual Meeting in Las Vegas, Nev. (March 16-21, 2019)

• Substantia nigra hyperintensities leads to diagnosis of Leber's hereditary optic neuropathy.
  

  Smith C, Darpel K, Echiverri K

American Neurological Association (ANA)
143^rd Annual Meeting in Atlanta, Ga. (Oct. 21-23, 2018)

• Disseminated mycobacterium avium-intracellulare presenting with multiple cranial neuropathies.
  

  Echiverri K, Pradeep S, Escott E, Sudhakar P

American Academy of Neurology (AAN)
70^th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)

• Spinal dural arteriovenous fistula and concomitant intramedullary spinal lesion.
  

  Nascimento F, Kan P, Sharp L, Mandel J

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
64^th Annual Meeting in Phoenix, Ariz. (Sept. 13-16, 2017)

• Eculizumab in refractory myasthenic crisis.
  

  Yeo C, Pleitez M

2017 Alzheimer's Association International Conference (AAIC)
London, United Kingdom (July 15-20, 2017)

• Predictors of atypical antipsychotic treatment in an AD clinical population.
  

  Pavlik VN, Bishop JS, Glosch C, Yu M, Darby E, Starks S, et al.

Society of General Internal Medicine (SGIM)
2017 Southern Regional Meeting in New Orleans, La. (Feb. 10-12, 2017)

• Ataxia: The first sign of breast cancer.
  

  Rizk CB, Savitt DJ, Yu M, Kung D

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
63^rd Annual Meeting in New Orleans, La. (Sept. 14-17, 2016)

• Chronic endurance exercise training in a mouse model of myotonic dystrophy type 1.
  

  Sharp L, Cooper T

• Oculomotor and masticator muscle enhancement in a case of multiple cranial nerve palsies and internuclear ophthalmoplegia associated with herpes simplex virus infection.
  

  Yeo C, Simpson E, Pleitez M, Smith R

Association of University Radiologists (AUR)
64^th Annual Meeting in San Diego, Calif. (March 29 - April 1, 2016)

• Comparing two ¹²³I-Ioflupane SPECT processing methods for determination of basal ganglia volumes in patients with parkinsonian-like features.
  

  Echiverri K, Sinha P, Cheatham E, Quintero G, van Horne C, Oates ME

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
62^nd Annual Meeting in Honolulu, Hawaii (Oct. 28-31, 2015)

• A rare heteroplasmic tRNALeu(CUN) mutation presenting with refractory seizures and myopathy.
  

  Shroff S, Nakawah M, Pleitez M, Rosenfield D, Simpson E

• Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
  [Previously Presented]
  

  Shroff S, Thonhoff J, Eatman J, Pleitez M, Rosenfield D

University of Kentucky
2015 Clinical & Translational Neuroscience Exposition in Lexington, Ky. (June 26, 2015)

• Headache and cutaneous allodynia in older adults without cognitive impairment.
  [Previously Presented]
  

  Echiverri K, Jicha GA, Smith JH

• Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
  [Previously Presented]
  

  Gan W, Echiverri K, Smith JH

American Headache Society
57^th Annual Scientific Meeting in Washington, DC (June 18-21, 2015)

• Headache and cutaneous allodynia in older adults without cognitive impairment.
  

  Echiverri K, Jicha GA, Smith JH

• Association between overall and mentholated cigarette smoking with headache: Results from the National Health and Nutrition Examination Survey 1999-2004.
  

  Gan W, Echiverri K, Smith JH

International Myotonic Dystrophy Consortium (IDMC)
10^th Meeting in Paris, France (June 8-10, 2015)

• Rationale for establishing a Myotonic Dystrophy Multidisciplinary Clinic.
  

  Shroff S, Thonhoff J, Eatman J, Pleitez M, Rosenfield D

American Academy of Neurology (AAN)
67^th Annual Meeting in Washington, DC (April 18-25, 2015)

• Atypical presentation of inclusion body myositis.
  

  Shroff S, Pleitez M

American Academy of Neurology (AAN)
66^th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)

• Oxidative metabolism during forearm exercise in McArdle disease.
  

  Haller R, Sharp L, Phillips L, Newby M, Wyrick P, Heinicke K

• A distinctive delayed form of exertional rhabdomyolysis.
  [Platform Presentation]
  

  Sharp L, Haller R

• Not PFK deficiency.
  

  Sharp L, Romain N, Haller R

Texas Scottish Rite Hospital for Children
36^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 13-14, 2014)

• A distinctive delayed form of exertional rhabdomyolysis.
  

  Sharp L, Haller RG

• Fixed weakness in McArdle disease.
  

  Sharp L, Haller RG

• Exercise intolerance with congenital anomalies.
  

  Sharp L, Haller RG, Heinicke K, Phillips L, Romain N, Park S, et al.

• Rare family with autosomal dominant oculopharyngeal muscular dystrophy showing anticipation.
  

  Smith S, Pleitez MY

American Academy of Neurology (AAN)
65^th Annual Meeting in San Diego, Calif. (March 16-23, 2013)

• Glycogen breakdown is preserved during exercise in severe muscle phosphorylase b kinase deficiency.
  [Previously Presented]
  

  Sharp L, Heinicke K, Ren J, Newby M, Wyrick P, Rice G, et al.

Texas Scottish Rite Hospital for Children
35^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 14-15, 2013)

• Glycogen breakdown is preserved during exercise.
  

  Sharp L, Heinicke K, Ren J, Newby M, Wyrick P, Rice G, et al.

• Not PFK deficiency.
  [Oral Presentation]
  

  Sharp L, Romain N, Haller RG

Texas Scottish Rite Hospital for Children
34^th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 23-24, 2012)

• Progressive weakness in a patient with static encephalopathy and colpocephaly.
  

  Phillips L, Sharp L, Herndon E, Pascual J, Trivedi J

Movement Disorder Society (MDS)
11^th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey (June 3-7, 2007)

• Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
  

  Sitburana O, Rountree S, Vuong KD, Ondo W

Movement Disorder Society (MDS)
10^th International Congress of Parkinson's Disease and Movement Disorders in Kyoto, Japan (Oct. 30 - Nov. 2, 2006)

• Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.
  

  Diamond AL, Vuong KD, Jankovic J

American Neurological Association (ANA)
131^st Annual Meeting in Chicago, Ill. (Oct. 8-11, 2006)

• Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.
  [Previously Presented]
  

  Diamond AL, Vuong KD, Jankovic J

American Academy of Neurology (AAN)
58^th Annual Meeting in San Diego, Calif. (April 1-8, 2006)

• Long term safety of deep brain stimulation for the treatment of Parkinson's disease.
  

  Kenney CJ, Vuong K, Hunter C, Almaguer M, Jankovic J

American Academy of Neurology (AAN)
57^th Annual Meeting in Miami Beach, Fla. (April 9-16, 2005)

• Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
  [Previously Presented]
  

  Shahed J, Diamond AL, Vuong KD, Jankovic J

Movement Disorder Society (MDS)
9^th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, La. (March 5-8, 2005)

• Gait and balance assessment in parkinsonian disorders.
  

  Azher SN, Vuong KD, Shahed J, Diamond AL, Jankovic J

• Globus pallidus deep brain stimulation in dystonia.
  

  Diamond AL, Shahed J, Azher SN, Vuong KD, Jankovic J

• Tetrabenazine: Does prior history of depression preclude this drug as a treatment option?
  

  Hunter C, Vuong KD, Mejia N, Jankovic J

• Medications associated with the onset of tardive dyskinesia.
  

  Mejia N, Vuong KD, Hunter C, Jankovic J

• Predictors of battery life for the Activa® Soletra 7426 neurostimulator.
  

  Ondo WG, Meilak C, Vuong KD, Jankovic J

• Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
  

  Shahed J, Diamond AL, Vuong KD, Jankovic J

American Neurological Association (ANA)
129^th Annual Meeting in Toronto, Canada (Oct. 4-5, 2004)

• The safety of deep brain stimulation in patients with Parkinson's disease, essential tremor, and other movement disorders.
  

  Silay Y, Jankovic J, Vuong KD, Almageur M, Ondo WG, Tintner R, et al.

Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
18^th Annual Symposium in Toronto, Canada (Oct. 3, 2004)

• Safety and efficacy of tetrabenazine in the treatment of Huntington's disease and other choreas.
  

  Jankovic J, Hunter CB, Vuong KD

Movement Disorder Society (MDS)
8^th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004)

• Tetrabenazine, a monoamine depleter, effective in the treatment of Tourette syndrome.
  

  Hunter C, Vuong KD, Mejia N, Jankovic J

• Tetrabenazine: Effective treatment for tardive dyskinesia.
  

  Jankovic J, Hunter C, Mejia N, Vuong KD

• Young-onset versus late-onset Parkinson's disease: Clinical features and disease progression.
  

  Silver GA, Vuong KD, Jankovic J

• Long-term prognosis of psychogenic movement disorders.
  

  Thomas M, Banuelos P, Vuong KD, Jankovic J

• Psychogenic dystonia: Clinical characteristics and long-term progression.
  

  Thomas M, Vuong KD, Jankovic J

• Safety and efficacy of tetrabenazine in childhood hyperkinetic movement disorders.
  

  Vuong KD, Hunter C, Mejia N, Jankovic J

American Academy of Neurology (AAN)
56^th Annual Meeting in San Francisco, Calif. (April 24 - May 1, 2004)

• Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
  

  Hunter CB, Vuong KD, Jankovic J

• Essential tremor in children.
  

  Jankovic J, Madisetty J, Vuong KD

• Psychogenic tremor: Long-term outcome.
  

  Jankovic J, Vuong KD, Thomas M

• The efficacy and safety of fluphenazine in patients with Tourette syndrome.
  

  Silay YS, Vuong KD, Jankovic J

American Society for Experimental NeuroTherapeutics (ASENT)
6^th Annual Meeting in Bethesda, Md. (March 11-13, 2004)

• Tetrabenazine in the treatment of chorea.
  

  Jankovic J, Hunter CB, Vuong KD

American Academy of Neurology (AAN)
55^th Annual Meeting in Honolulu, Hawaii (March 29 - April 5, 2003)

• Long term treatment of restless legs syndrome with dopamine agonists.
  

  Ondo WG, Romanyshyn J, Vuong KD

Movement Disorder Society (MDS)
7^th International Congress of Parkinson's Disease and Movement Disorders in Miami, Fla. (Nov. 10-14, 2002)

• Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism.
  

  Hill AN, Jankovic J, Vuong KD, Donovan D

• Age-related tolerability of tetrabenazine.
  

  Hunter CB, Wang A, Vuong KD, Jankovic J

• Tetrabenazine in the treatment of Tourette syndrome.
  

  Hunter CB, Wang A, Vuong KD, Jankovic J

• Evaluating factors that can influence spirography ratings in patients with essential tremor.
  

  Ondo WG, Wang A, Thomas M, Vuong KD

• Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease.
  

  Tintner R, Almaguer M, Vuong KD, Ondo WG, Jankovic J, Sanghera M

American Headache Society
44^th Annual Scientific Meeting in Seattle, Wash. (June 21-23, 2002)

• Botulinum toxin A (Botox) for chronic daily headache: A randomized placebo-controlled, parallel design study.
  

  Ondo WG, Vuong KD, Derman HS

Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins
International Conference in Hannover, Germany (June 8, 2002)

• Comparison of immunogenicity of old versus current Botox in cervical dystonia.
  

  Jankovic J, Ahsan J, Vuong KD

American Academy of Neurology (AAN)
53^rd Annual Meeting in Philadelphia, Penn. (May 5-11, 2001)

• The prevalence of restless legs syndrome in patients with Parkinson's disease.
  

  Atassi F, Vuong KD, Jankovic J, Ondo WG

• Exploring the relationship between Parkinson's disease and restless legs syndrome.
  

  Ondo WG, Vuong KD, Jankovic J

Movement Disorder Society (MDS)
6^th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000)

• Olanzapine treatment for dopaminergic induced hallucinations.
  

  Ondo WG, Hunter C, Vuong KD, Jankovic J

• Daytime sleepiness in patients with Parkinson's disease.
  

  Ondo WG, Vuong KD, Atassi F, Khan H, Kwak C, Jankovic J

American Academy of Neurology (AAN)
52^nd Annual Meeting in San Diego, Calif. (April 29 - May 6, 2000)

• Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation.
  

  Vuong KD, Ondo WG, Almaguer M, Simpson RK, Jankovic J